Can anyone or Prof please explain what it means by orphan drug status? Why is it good for PRR? etc.
Sorry, I am pretty new in this area.
Wiki as reference is ok. I know I can do a google search, but I think it is better that someone who knows these thing explain it in a short and nice, straight to the point kind of way; Also good for people who read this thread to gain more understanding.
Thanks!
patient numbers required for clinical study , page-25
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.015(3.57%) |
Mkt cap ! $631.8M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 44.0¢ | 41.5¢ | $1.416M | 3.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 38735 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 41215 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |